Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics - Endpoints News

Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics - Endpoints News
Business

Listen to this article

0%

VerΒ­tex PharΒ­maΒ­ceuΒ­tiΒ­cals is makΒ­ing the largest acΒ­quiΒ­siΒ­tion in its hisΒ­toΒ­ry, beefΒ­ing up its comΒ­merΒ­cial portΒ­foΒ­lio with a $10 bilΒ­lion takeover of CriΒ­netΒ­ics PharΒ­maΒ­ceuΒ­tiΒ­cals. The Mon… [+3 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected